bioAffinity Technologies, Inc. (BIAF)

NASDAQ: BIAF · IEX Real-Time Price · USD
2.82
+0.06 (2.17%)
Oct 6, 2022 10:29 AM EDT - Market open

Company Description

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics.

The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.

The company was founded in 2014 and is based in San Antonio, Texas.

bioAffinity Technologies, Inc.
bioAffinity Technologies logo
Country United States
Founded 2014
IPO Date Sep 1, 2022
Industry Diagnostics & Research
Sector Health Care
Employees 11
CEO Maria Zannes

Contact Details

Address:
22211 W Interstate 10, Suite 1206
San Antonio, TX 78257
United States
Phone 210 698 5334

Stock Details

Ticker Symbol BIAF
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
IPO Price $6.13
CIK Code 1712762
SIC Code 8731

Key Executives

Name Position
Maria Zannes J.D. Founder, President, Chief Executive Officer and Director
Dr. Vivienne I. Rebel M.D., Ph.D. Executive Vice President and Chief Medical and Science Officer
Michael Edwards CPA, M.B.A. Chief Financial Officer
Xavier T. Reveles M.S. Vice President of Operations
Timothy P. Zannes J.D. Executive Vice President, Secretary and General Counsel
Dr. William Bauta Ph.D. Senior Vice President of Therapeutics

Latest SEC Filings

Date Type Title
Sep 28, 2022 8-K Current Report
Sep 6, 2022 8-K Current Report
Sep 2, 2022 424B4 Prospectus
Aug 29, 2022 EFFECT Notice of Effectiveness
Aug 23, 2022 8-A12B/A Filing
Aug 18, 2022 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Aug 9, 2022 CERT Certification by an exchange approving securities for listing
Aug 5, 2022 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Aug 2, 2022 8-A12B Registration of securities
Aug 2, 2022 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933